| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2,080 | $220 | $452.6K |
| J0178 | Injection, aflibercept, 1 mg | 480 | $680 | $325.9K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 9,780 | $30 | $273.8K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,490 | $110 | $158.4K |
| J3490 | Unclassified drugs | 120 | $1,240 | $143.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 890 | $110 | $95.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,790 | $30 | $60.7K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 270 | $120 | $32.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 200 | $130 | $25.2K |
| 67039 | The provider removes vitreous humor from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. This procedure also includes the… | 20 | $820 | $15.6K |